Transcranial rotating permanent magnet stimulation for focal continuous spike-and-wave during sleep: First-in-human pediatric pilot study.
Ten children completed one monitored session of a wearable rotating-permanent-magnet intervention without a serious event, and their short-term EEG spike burden decreased. The study did not test symptoms, learning, durability or benefit against sham treatment.
Bansal L, Pawar K, Vargas L, Helekar SA.
Seizure · Publication date: 2026-09-15
Added to site: 2026-09-21
DOI: 10.1016/j.seizure.2026.09.012
Electronic publication date verified in Europe PMC; the record was first indexed September 21, 2026.
- Modalities
- Permanent magnet stimulation, EEG, Neuromodulation
- Clinical focus
- Continuous spike-and-wave during sleep, Pediatric epilepsy, Safety and feasibility
- Population
- Children with focal CSWS undergoing inpatient epilepsy monitoring
- Sample
- 10 children ages 3 to 14 with focal continuous spike-and-wave during sleep
- Intervention / method
- One 10-minute focal stimulation session targeted to the scalp-EEG-defined epileptogenic region, with continuous video EEG before and after
- Comparator
- Within-participant pre-post comparison without sham or untreated control; two blinded pediatric epileptologists independently scored spike-wave index
Clinician summary
Both blinded reviewers found lower sleep and awake spike-wave index after a single session, and five participants crossed the predefined sleep-SWI response threshold. No serious adverse events, induced seizures, significant vital-sign changes or device complications were reported during this limited observation.
How to interpret the findings
This was an open-label, uncontrolled study of ten children after one 10-minute session. The primary outcome was an acute electrophysiologic measure, not cognition, seizure frequency or function. Small-sample safety observations cannot establish broader safety, and durability is unknown.
Equipment and disclosures
The intervention was a novel wearable transcranial rotating permanent magnet stimulation platform targeted from scalp EEG. Device model, field specifications and manufacturer were not available in the checked abstract; this was not described as PEMF.
Funding and competing-interest details were not available in the checked indexed record.
Related evidence
Compare findings from the same clinical area, including mixed results.
Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.